Medicamen Biotech Ltd

NSE: MEDICAMEQ BSE: 531146

₹223.30

(-6.49%)

Wed, 01 Apr 2026, 01:53 pm

MTF 5xInvest in Medicamen Biotech Ltd with 5x Leverage Buy with MTF

Market Cap3.05B

PE Ratio31.60

Dividend0.42

Health Technology

Pharmaceuticals: Major

24.5K

Medicamen Biotech Financials

Income Statement Balance Sheet Cashflow

Particulars	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total revenue	520.35M	600.31M	769.13M	863.35M	1.02B	1.23B	1.01B	639.98M	732.49M	777.94M	672.76M	824.50M	1.11B	1.23B	1.26B	1.13B	1.15B	1.41B	1.79B	1.63B
Gross profit	85.18M	90.10M	109.52M	139.90M	235.91M	224.80M	104.29M	51.94M	113.11M	110.25M	107.77M	172.91M	216.06M	210.72M	229.77M	219.92M	277.14M	274.45M	326.11M	225.81M
Operating expenses (excl. COGS)	-67.90M	-70.81M	-81.23M	-105.59M	-172.18M	-178.68M	-98.95M	-81.96M	-76.92M	-80.81M	-71.39M	-76.23M	-68.67M	-56.08M	-55.52M	-44.96M	-90.08M	-91.99M	-159.00M	-149.29M
Selling/general/admin expenses, total	-67.10M	-70.21M	-80.40M	-104.68M	-172.18M	-178.68M	-89.70M	-75.48M	-68.25M	-71.54M	-61.24M	-63.56M	-64.16M	-49.82M	-55.34M	-44.27M	-88.84M	-91.67M	-157.74M	-148.92M
Research & development	0	0	0	0	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Selling/general/admin expenses, other	-67.10M	-70.21M	-80.40M	-104.68M	-172.18M	-178.68M	-89.70M	-75.48M	-68.25M	-71.54M	-61.24M	-63.56M	-64.16M	-49.82M	-55.34M	-44.27M	-88.84M	-91.67M	-157.74M	-148.92M
Other operating expenses, total	-800.00K	-600.00K	-832.50K	-910.00K	0	0	-9.25M	-6.48M	-8.67M	-9.27M	-10.15M	-12.67M	-4.51M	-6.26M	-175.06K	-692.75K	-1.24M	-322.00K	-1.26M	-377.00K
Operating income	17.29M	19.28M	28.29M	34.32M	63.74M	46.11M	5.34M	-30.02M	36.19M	29.44M	36.39M	96.68M	147.38M	154.64M	174.25M	174.96M	187.07M	182.46M	167.12M	76.52M
Non-operating income, total	-195.85K	-1.57M	-10.25M	-17.69M	-4.69M	-3.04M	-11.77M	-18.73M	-34.40M	-28.23M	-29.27M	-33.09M	-8.38M	20.59M	5.55M	-11.02M	-6.12M	-12.01M	-36.36M	22.28M
Interest expense, net of interest capitalized	-6.83M	-6.75M	-15.31M	-13.87M	-12.24M	-17.72M	-19.15M	-26.05M	-40.46M	-39.24M	-36.20M	-36.10M	-27.12M	-13.82M	-9.32M	-15.12M	-19.41M	-33.92M	-56.72M	-37.20M
Interest capitalized	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non-operating income, excl. interest expenses	6.63M	5.17M	5.06M	-3.82M	7.56M	14.68M	7.38M	7.32M	6.06M	11.00M	6.93M	3.01M	18.74M	34.42M	13.93M	4.06M	13.22M	21.74M	19.62M	59.46M
Non-operating interest income	72.45K	123.79K	52.46K	275.80K	594.67K	795.52K	1.48M	2.15M	1.37M	2.12M	1.38M	733.00K	1.95M	9.25M	3.20M	1.53M	1.35M	7.21M	7.24M	5.07M
Miscellaneous non-operating expense	6.56M	5.05M	5.00M	-4.10M	6.96M	13.89M	5.90M	5.17M	4.69M	8.88M	5.55M	2.28M	16.78M	25.17M	10.74M	2.52M	11.87M	14.53M	12.38M	54.39M
Unusual income/expense	—	—	—	—	—	—	—	—	—	—	—	—	—	—	936.65K	41.48K	64.88K	167.00K	733.00K	24.00K
Pretax income	17.09M	17.71M	18.04M	16.63M	59.05M	43.07M	-6.43M	-48.76M	1.79M	1.21M	7.12M	63.59M	139.00M	175.23M	179.80M	163.94M	180.94M	170.45M	130.76M	98.80M
Taxes	-2.15M	-2.65M	-2.94M	-2.85M	-19.29M	-15.30M	-1.81M	-520.71K	-845.40K	3.20M	-2.31M	-11.99M	-37.87M	-54.97M	-46.89M	-42.65M	-31.97M	-23.16M	-35.82M	-33.24M
Non-controlling/minority interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.16M	14.37M	5.53M
After tax other income/expense	0	0	0	0	0	—	—	—	0	0	0	0	0	0	0	0	0	0	0	0
Net income before discontinued operations	14.94M	15.06M	15.10M	13.77M	39.76M	27.77M	-8.25M	-49.28M	941.82K	4.41M	4.81M	51.60M	101.13M	120.26M	132.91M	121.29M	148.97M	148.44M	109.31M	71.08M
Net income	14.94M	15.06M	15.10M	13.77M	39.76M	27.77M	-8.25M	-49.28M	941.82K	4.41M	4.81M	51.60M	101.13M	120.26M	132.91M	121.29M	148.97M	148.44M	109.31M	71.08M
Dilution adjustment	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred dividends	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Diluted net income available to common stockholders	14.94M	15.06M	15.10M	13.77M	39.76M	27.77M	-8.25M	-49.28M	941.82K	4.41M	4.81M	51.60M	101.13M	120.26M	132.91M	121.29M	148.97M	148.44M	109.31M	71.08M
Basic earnings per share (Basic EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted earnings per share (Diluted EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	23.31M	25.87M	37.24M	44.65M	75.39M	59.82M	20.36M	-14.25M	52.28M	50.41M	55.36M	115.90M	167.96M	176.78M	199.24M	200.16M	244.78M	255.21M	247.88M	147.40M
EBIT	17.29M	19.28M	28.29M	34.32M	63.74M	46.11M	5.34M	-30.02M	36.19M	29.44M	36.39M	96.68M	147.38M	154.64M	174.25M	174.96M	187.07M	182.46M	167.12M	76.52M
Total operating expenses	-503.06M	-581.03M	-740.84M	-829.03M	-952.37M	-1.18B	-999.93M	-670.00M	-696.30M	-748.49M	-636.37M	-727.82M	-967.61M	-1.07B	-1.08B	-952.20M	-967.39M	-1.23B	-1.63B	-1.55B
Prepaid expenses	—	—	—	—	—	—	1.01M	1.01M	1.02M	993.16K	639.94K	4.97M	6.66M	43.90M	44.65M	51.41M	39.79M	33.29M	33.43M	15.36M
Deferred income, current	—	—	—	—	—	—	—	—	26.42M	—	7.18M	4.89M	7.01M	39.20M	—	—	—	—	—	—
Capital and operating lease obligations	3.05M	2.30M	3.13M	1.96M	1.47M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating lease liabilities	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax liabilities	2.15M	2.61M	3.32M	4.30M	5.14M	7.32M	8.95M	9.47M	9.97M	6.55M	7.42M	6.44M	4.14M	4.14M	1.64M	2.83M	—	—	—	—
Deferred income, non-current	0	0	0	0	0	—	—	0	0	0	0	0	0	—	—	—	—	—	—	—
Minority interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in accrued expenses	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Common dividends paid	0	0	0	0	0	-5.79M	0	0	0	0	0	0	-13.32M	0	-14.70M	-6.11M	-12.22M	-12.65M	-12.65M	-12.71M
Preferred dividends paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800